Avacta Group Plc (LON:AVCT – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 111.41 ($1.41) and traded as low as GBX 50.18 ($0.63). Avacta Group shares last traded at GBX 50.44 ($0.64), with a volume of 2,491,929 shares changing hands.
Avacta Group Price Performance
The company has a debt-to-equity ratio of 225.41, a current ratio of 0.71 and a quick ratio of 4.96. The company’s 50 day moving average price is GBX 79.30 and its 200 day moving average price is GBX 110.64. The firm has a market capitalization of £154.71 million, a P/E ratio of -306.25 and a beta of 1.21.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
See Also
- Five stocks we like better than Avacta Group
- What is a Low P/E Ratio and What Does it Tell Investors?
- Best Bear Market Funds: Top 3 Investment Options to Consider
- P/E Ratio Calculation: How to Assess Stocks
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- The How and Why of Investing in Biotech Stocks
- Mid-Cap Stocks to Outperform the Market This Cycle
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
